Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Terminated 9Completed 9Recruiting 3Active not recruiting 3Unknown 2Not yet recruiting 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Sarcoma 1Myeloid 1Dermatologic 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Burkitt Lymphoma 17Lymphoma, Large B-Cell, Diffuse 12Neuroblastoma 7Lymphoma, Follicular 7Lymphoma, B-Cell 7Leukemia, Biphenotypic, Acute 7Rhabdomyosarcoma 6Lymphoma, T-Cell, Peripheral 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Sarcoma, Ewing 4Lymphoma 4Retinoblastoma 3Recurrence 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Osteosarcoma 3Medulloblastoma 3Lymphoma, T-Cell 3Lymphoma, Non-Hodgkin 3Wilms Tumor 2Sarcoma 2Plasmablastic Lymphoma 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, B-Cell 2Hodgkin Disease 2Ganglioneuroblastoma 2Blastic Plasmacytoid Dendritic Cell Neoplasm 2Stage I Mixed Cell Type Kidney Wilms Tumor 1Rhabdomyosarcoma, Embryonal 1Rhabdoid Tumor 1

Interventions

Cyclophosphamide 21venetoclax 18pembrolizumab 16Dexamethasone 16fludarabine 14Cytarabine 13Gemcitabine 9pomalidomide 8Rituximab 8Carboplatin 8Azacitidine 8glofitamab 7fludarabine phosphate 7Lenalidomide 7Immunotherapy, Adoptive 7selinexor 6Paclitaxel 6Injections 6Granulocyte Colony-Stimulating Factor 6Cisplatin 6daratumumab 5Temozolomide 5Oxaliplatin 5Bevacizumab 5zanubrutinib 4ruxolitinib 4Surgical Procedures, Operative 4Nivolumab 4Drug Therapy 4Decitabine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Recurrence × Vincristine × Clear all
NCT06721689 2026-04-15

PEEL-224

Children's Hospital of Philadelphia

Phase 1/2 Recruiting
59 enrolled
CNSSarcoma

Neuroblastoma, Recurrence, Rhabdomyosarcoma

NCT05996185 2026-04-14

Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma

Yale University

Phase 2 Recruiting
22 enrolled
DermatologicLymphoidOther hematologic neoplasm

Recurrence, Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT05292664 2026-03-12

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Dana-Farber Cancer Institute

Phase 1 Recruiting
30 enrolled
LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Neoplasm Metastasis, Recurrence, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡